Transplant News and Research

RSS

Widely used hospital gowns show signs of exposing workers to infection

Disposable gowns designed to deflect the splatter of bodily fluids, used in thousands of U.S. hospitals, have underperformed in recent and ongoing laboratory tests and may fall short of safety standards, leaving health care workers with a greater risk of infection than advertised.

6 Jul 2022

Intrahost genetic diversity and evolution of the SARS-CoV-2 B.1.517 lineage during chronic infection of an immunocompromised individual

Researchers investigated the intrahost evolution and genetic diversity of the SARS-CoV-2 B.1.517 variant in an immunosuppressed person with chronic COVID-19.

6 Jul 2022

Scientists demonstrate key role of an enzyme in facilitating ovarian cancer metastasis in the omentum

In their recent publication in Cell Reports, a team of scientists, led by Xiling Shen, Ph.D., Chief Scientific Officer at the Terasaki Institute for Biomedical Innovation (TIBI), has demonstrated the pivotal role of an enzyme, glucose-6-phosphate dehydrogenase (G6PD), in facilitating ovarian cancer (OC) growth and metastasis in the omentum, a curtain of fatty tissue found in the abdominal cavity.

2 Jul 2022

Study provides better understanding of how therapeutic resistance develops in lung cancer

New Cleveland Clinic research has uncovered key information about cellular interaction between tumor cells and normal tissue, providing better understanding of how therapeutic resistance develops.

1 Jul 2022

Remdesivir resistance in renal transplant patients with long COVID-19

A new study has reported two renal transplant cases, in which individuals, after being exposed to remdesivir, developed a resistance to the drug.

1 Jul 2022

New signaling molecule may offer a therapeutic treatment for common form of hair loss

University of California, Irvine-led researchers have discovered that a signaling molecule called SCUBE3 potently stimulates hair growth and may offer a therapeutic treatment for androgenetic alopecia, a common form of hair loss in both women and men.

30 Jun 2022

New robotic AI system can autonomously determine the optimal conditions for growing replacement retina

A joint research group led by Genki Kanda at the RIKEN Center for Biosystems Dynamics Research (BDR) has developed a robotic artificial intelligence (AI) system for autonomously determining the optimal conditions for growing replacement retina layers necessary for vision.

29 Jun 2022

Study explores antibody responses following three COVID vaccine doses in kidney transplant recipients

In a recent study posted to the medRxiv* pre-print server, Canadian researchers evaluated antibody responses in kidney transplant recipients (KTRs) before and one and three months after receiving the third dose of a messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccine.

28 Jun 2022

NYU Langone Health continues to broaden access to high-quality care with recent expansions

NYU Langone Health continues to broaden access to high-quality primary and specialty care with recent expansions on Long Island and in Brooklyn and southeast Florida.

28 Jun 2022

New tissue model helps trace the steps involved in liver regeneration

The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.

27 Jun 2022

Studies discover multiple gene variants that contribute to the risk and severity of NAFLD in children

In a pair of overlapping studies, a diverse team of researchers, led by scientists at University of California San Diego School of Medicine, have deepened investigations into the genetic origins of nonalcoholic fatty liver disease (NAFLD) in children, describing multiple gene variants (including some previously unknown) that contribute to the risk of developing NAFLD and gene variants associated with the severity of the liver disease.

27 Jun 2022

Chemically modified rocaglates have a stronger effect against viral replication

Hepatitis E virus (HEV) is widespread, and so far there is no effective drug. In the search for one, the so-called rocaglates have come into focus: plant compounds that can inhibit the replication of viruses.

27 Jun 2022

Antibody profiles of internal viral proteins predict severe COVID-19 outcomes

Most research on immunity to the SARS-CoV-2 virus and COVID-19 vaccine development has focused on antibody responses to the spike protein and other viral surface proteins.

24 Jun 2022

Novel drug molecule targets T-cells causing inflammation in heart failure patients

Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a novel drug molecule that targets T-cells causing inflammation in heart failure patients, stopping further progression of the disease.

22 Jun 2022

Study finds vaccination hesitancy among parents of children with kidney disease or hypertension

In this study published in the American Journal of Kidney Diseases (AJKD), over 60% of surveyed parents of children with kidney disease or hypertension reported they were unsure or unwilling to vaccinate their child against COVID-19.

21 Jun 2022

New method can safely free patients from lifelong immunosuppression after kidney transplant

Physicians at Stanford Medicine have developed a way to provide pediatric kidney transplants without immune-suppressing drugs.

17 Jun 2022

Genetic screening algorithm can estimate a person's risk of developing chronic kidney disease

A new algorithm developed by researchers at Columbia University can analyze thousands of variants across the genome and estimate a person's risk of developing chronic kidney disease - and it works in people of African, Asian, European, and LatinX descent.

16 Jun 2022

Fecal microbiota transplant shows durable effect in treating irritable bowel syndrome

A new study discusses the efficacy of fecal transplant in patients with IBS three years after the procedure was performed.

16 Jun 2022

KHN’s ‘What the Health?’: Closing in on covid vaccines for ‘the littles’

Children younger than 5 are the only population not eligible for a covid-19 vaccine in the U.S. But that may be about to change as an advisory committee to the Food and Drug Administration recommends authorization for that group.

16 Jun 2022

Drug combinations may help to slow the progression of diabetic kidney disease

A mouse study led by Washington University School of Medicine in St. Louis suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.

15 Jun 2022

Transplant News and Research

Widely used hospital gowns show signs of exposing workers to infection

Intrahost genetic diversity and evolution of the SARS-CoV-2 B.1.517 lineage during chronic infection of an immunocompromised individual

Scientists demonstrate key role of an enzyme in facilitating ovarian cancer metastasis in the omentum

Study provides better understanding of how therapeutic resistance develops in lung cancer

Remdesivir resistance in renal transplant patients with long COVID-19

New signaling molecule may offer a therapeutic treatment for common form of hair loss

New robotic AI system can autonomously determine the optimal conditions for growing replacement retina

Study explores antibody responses following three COVID vaccine doses in kidney transplant recipients

NYU Langone Health continues to broaden access to high-quality care with recent expansions

New tissue model helps trace the steps involved in liver regeneration

Studies discover multiple gene variants that contribute to the risk and severity of NAFLD in children

Chemically modified rocaglates have a stronger effect against viral replication

Antibody profiles of internal viral proteins predict severe COVID-19 outcomes

Novel drug molecule targets T-cells causing inflammation in heart failure patients

Study finds vaccination hesitancy among parents of children with kidney disease or hypertension

New method can safely free patients from lifelong immunosuppression after kidney transplant

Genetic screening algorithm can estimate a person's risk of developing chronic kidney disease

Fecal microbiota transplant shows durable effect in treating irritable bowel syndrome

KHN’s ‘What the Health?’: Closing in on covid vaccines for ‘the littles’

Drug combinations may help to slow the progression of diabetic kidney disease

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News